Company Name:Alkermes plc
CEO: Richard F. Pops

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Alkermes PLC is a fully integrated, biopharmaceutical company. It applies its scientific expertise and proprietary technologies to research, develop and commercialize pharmaceutical products to address unmet medical needs of patients.


Key numbers

Market Capitalization:2701502300
Shares Outstanding: 157522000
Float: 156009159
Next Earning Date:2020-02-17
TTm EPS: -1.2829
TTm Dividend Rate:
200 days moving average:22.13
50 days moving average: 20.16
One day percent Change: -2.67



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,